Discovery of potent and selective CK1α molecular degrader with a favorable safety profile for acute myeloid leukemia and solid tumors

被引：0
|
作者：
Kong, Jinuk
Park, Jisu
Lee, Heekyu
Kang, Hyunseok
Lee, Deokjae
Jo, Hyunsun
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-4950
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4950
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Discovery of SZJK-0421: A Novel Potent, Low Toxicity, Selective Second Generation of CRM1 Inhibitor for the Treatment of Both Hematological and Solid Tumors
    Miao, Hang
    Qin, Yanru
    Shao, DingLu
    Chen, Qinghua
    Pan, Yupeng
    Lei, Meng
    Wu, Ruokun
    Ye, Xinran
    Wang, Xueyuan
    Zhu, Yongqiang
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (22) : 20595 - 20618
  • [42] Discovery of indirubin-3′-aminooxy-acetamide derivatives as potent and selective FLT3/D835Y mutant kinase inhibitors for acute myeloid leukemia
    Lee, Je-Heon
    Shin, Ji Eun
    Kim, WooChan
    Jeong, Pyeonghwa
    Kim, Myung Jin
    Oh, Su Jin
    Park, Hyun Woo
    Han, Sun-Young
    Kim, Yong-Chul
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 237
  • [43] Discovery and development of IACS-010759, a novel inhibitor of Complex I currently in phase I studies to exploit oxidative phosphorylation dependency in acute myeloid leukemia and solid tumors
    Di Francesco, Maria Emilia
    Marszalek, Joseph R.
    McAfoos, Timothy
    Carroll, Christopher L.
    Kang, Zhijun
    Liu, Gang
    Theroff, Jay P.
    Bardenhager, Jennifer P.
    Bandi, Madhavi L.
    Molina, Jennifer R.
    Gera, Sonal
    Protopopova, Marina
    Sun, Yuting
    Do, Mary K. Geck
    Feng, Ningping
    Gay, Jason P.
    Muller, Florian
    Konopleva, Marina
    Meric-Bernstam, Funda
    Toniatti, Carlo
    Heffernan, Timothy P.
    Draetta, Giulio F.
    Jones, Philip
    CANCER RESEARCH, 2018, 78 (13)
  • [44] A Phase I safety and tolerance study of FN-1501, a novel FLT3 inhibitor, in patients with advanced solid tumors and acute myeloid leukemia.
    Richardson, Gary Edward
    Williamson, Stephen K.
    Nagasaka, Misako
    Bozon, Viviana
    Corvez, Maria Margarita
    Li, Chao
    Li, Wei
    Wei, Jiao
    Hui, Ai-Min
    CANCER RESEARCH, 2021, 81 (13)
  • [45] Potent and Highly Selective Aldo-Keto Reductase 1C3 (AKR1C3) Inhibitors Act as Chemotherapeutic Potentiators in Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic Leukemia
    Verma, Kshitij
    Zang, Tianzhu
    Penning, Trevor M.
    Trippier, Paul C.
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (07) : 3590 - 3616
  • [46] Identification of epitopes of cancer testis antigen cyclin A1 for targeted T-cell therapy of acute myeloid leukemia (AML) and solid tumors
    Teck, Anja-Tatjana
    Urban, Sabrina
    Quass, Petra
    Nelde, Annika
    Walz, Juliane
    Keilholz, Ulrich
    Ochsenreither, Sebastian
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [47] Asciminib Provides Durable Responses and a Favorable Safety Profile in Patients with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) with the T315I Mutation in a Phase 1 Study
    Cortes, Jorge E.
    Hughes, Timothy P.
    Mauro, Michael J.
    Hochhaus, Andreas
    Rea, Delphine
    Goh, Yeow-Tee
    Janssen, J. J. W. M.
    Heinrich, Michael C.
    Talpaz, Moshe
    Etienne, Gabriel
    Breccia, Massimo
    Deininger, Michael
    Le Coutre, Philipp
    Lang, Fabian
    Polydoros, Fotis
    Cacciatore, Silvia
    Stenson, Laura
    Kim, Dong-Wook
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S335 - S336
  • [48] Preliminary Safety and Efficacy Of BGB-11417, a Potent and Selective B-Cell Lymphoma 2 (BCL2) Inhibitor, in Patients (Pts) with Acute Myeloid Leukemia (AML)
    Shortt, Jake
    Platzbecker, Uwe
    Tan, Shuh Ying
    Cannell, Paul
    Ng, Teng Fong
    Fong, Chun Yew
    Ramanathan, Sundra
    Rajagopal, Rajeev
    Leitch, Sophie
    Gasiorowski, Robin
    Grove, Carolyn
    Lenton, Douglas
    Tan, Peter
    Dinardo, Courtney
    Ling, Ming Tat
    Cheng, Si
    Liu, Yuan
    Co, Melannie
    Chan, Wai Y.
    Simpson, David
    Wei, Andrew H.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 144 - 144
  • [49] Development of a Robust Scale-Up Synthetic Route for BPR1K871: A Clinical Candidate for the Treatment of Acute Myeloid Leukemia and Solid Tumors
    Reddy, Julakanti Satyanarayana
    Chen, Chih-Ming
    Coumar, Mohane Selvaraj
    Sun, Hsu-Yi
    Sun, Na
    Hsieh, Hsing-Pang
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2021, 25 (04) : 817 - 830
  • [50] Discovery of Dual CDK6/PIM1 Inhibitors with a Novel Structure, High Potency, and Favorable Druggability for the Treatment of Acute Myeloid Leukemia (vol 65, pg 857, 2022)
    Yuan, Kai
    Ji, Minghui
    Qiu, Zhixia
    Chen, Weijiao
    Min, Wenjian
    Xia, Fei
    Zheng, Mingming
    Wang, Xiao
    Li, Jiaxing
    Hou, Yi
    Kuang, Wenbin
    Wang, Liping
    Gu, Wanjian
    Li, Zhiyu
    Yang, Peng
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (09) : 6969 - 6970
12345